Profile data is unavailable for this security.
About the company
Mochida Pharmaceutical Co Ltd is a Japan-based company principally engaged in the production and sale of drugs. The Pharmaceutical-related segment is engaged in the manufacture, purchase and sale of pharmaceutical products. The Company also conducts brokerage and management of real estate properties, the maintenance and management of buildings, the agency of personal affairs, accounting and purchasing businesses. The Healthcare segment is involved in the manufacture, purchase and sale of quasi drugs and cosmetic products.
- Revenue in JPY (TTM)109.37bn
- Net income in JPY9.58bn
- Incorporated1945
- Employees1.54k
- LocationMochida Pharmaceutical Co Ltd1-1, Ichigayahommura-choSHINJUKU-KU 162-0845JapanJPN
- Phone+81 333587211
- Fax+81 333587887
- Websitehttp://www.mochida.co.jp
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Eiken Chemical Co Ltd | 44.52bn | 6.87bn | 72.19bn | 745.00 | 8.97 | 1.25 | 8.07 | 1.62 | 184.75 | 184.75 | 1,197.16 | 1,327.27 | 0.7103 | 2.76 | 3.52 | 59,758,390.00 | 10.97 | 8.28 | 13.95 | 10.85 | 48.79 | 45.35 | 15.44 | 11.04 | 2.17 | -- | 0.0576 | 31.27 | 11.20 | 5.26 | 23.28 | 16.34 | 20.51 | 15.33 |
| TORII PHARMACEUTICAL CO., LTD. | 48.87bn | 3.99bn | 88.70bn | 560.00 | 21.68 | 0.7318 | 19.97 | 1.82 | 142.09 | 142.09 | 1,739.26 | 4,209.04 | 0.3782 | 2.73 | 2.41 | 87,258,930.00 | 3.09 | 6.82 | 3.37 | 7.85 | 49.14 | 51.06 | 8.17 | 15.53 | 8.03 | -- | 0.00 | 16.78 | 12.68 | -4.84 | -3.46 | 3.51 | -13.22 | 0.00 |
| Shin Nippon Biomedical Laboratories Ltd | 20.14bn | 8.04bn | 95.13bn | 994.00 | 11.83 | 3.82 | 10.10 | 4.72 | 193.21 | 193.21 | 483.67 | 597.85 | 0.4299 | 1.62 | 6.73 | 20,257,290.00 | 17.21 | 5.06 | 25.22 | 7.65 | 53.50 | 45.48 | 40.03 | 14.97 | 0.9142 | -- | 0.4231 | 24.13 | 17.46 | 0.5778 | 94.65 | -- | 9.71 | -- |
| TOWA PHARMACEUTICAL CO., LTD | 173.86bn | 9.36bn | 105.30bn | 4.08k | 10.95 | 0.7252 | 4.50 | 0.6057 | 186.62 | 186.62 | 3,473.48 | 2,818.59 | 0.5752 | 1.45 | 3.68 | 42,633,890.00 | 3.10 | 5.90 | 4.33 | 7.84 | 39.10 | 44.12 | 5.39 | 10.22 | 0.8056 | -- | 0.518 | 16.48 | 6.92 | 14.28 | 14.01 | 23.34 | -8.50 | 12.47 |
| KYORIN Holdings, Inc. | 105.53bn | 5.05bn | 110.87bn | 2.22k | 19.46 | 0.7883 | 12.54 | 1.05 | 88.18 | 88.18 | 1,841.56 | 2,176.73 | 0.621 | 1.30 | 3.04 | 47,491,000.00 | 2.97 | 3.33 | 3.66 | 4.03 | 46.13 | 51.06 | 4.79 | 5.46 | 1.87 | -- | 0.1443 | 70.59 | 2.56 | -1.77 | -35.86 | -11.65 | 0.338 | -2.16 |
| Zeria Pharmaceutical Co Ltd | 64.64bn | 5.84bn | 115.80bn | 1.74k | 16.61 | 1.56 | 10.15 | 1.79 | 131.27 | 131.27 | 1,450.17 | 1,395.01 | 0.5009 | 1.46 | 3.79 | 37,213,090.00 | 4.54 | 3.10 | 7.27 | 4.98 | 71.69 | 71.28 | 9.07 | 5.92 | 0.7455 | 6.65 | 0.4665 | 45.87 | 12.84 | -1.70 | 26.03 | 2.25 | -17.52 | 1.81 |
| Kissei Pharmaceutical Co Ltd | 65.86bn | 10.58bn | 132.27bn | 1.83k | 11.13 | 0.5884 | 9.03 | 2.01 | 229.45 | 229.45 | 1,428.10 | 4,338.62 | 0.2718 | 1.75 | 3.00 | 36,026,800.00 | 4.41 | 3.16 | 4.79 | 3.42 | 48.53 | 55.98 | 16.23 | 10.45 | 4.82 | -- | 0.0079 | 34.12 | -5.31 | -1.83 | 144.48 | 10.83 | -5.39 | 4.01 |
| Mochida Pharmaceutical Co Ltd | 109.37bn | 9.58bn | 138.55bn | 1.54k | 13.65 | 0.9957 | 11.33 | 1.27 | 252.77 | 252.77 | 2,899.75 | 3,464.88 | 0.678 | 2.24 | 3.58 | 70,835,500.00 | 5.94 | 5.22 | 7.12 | 6.40 | 53.99 | 51.57 | 8.75 | 7.76 | 3.62 | -- | 0.00 | 40.56 | 6.98 | 2.51 | 23.08 | 4.39 | 21.99 | 3.04 |
| Sawai Group Holdings Co Ltd | 192.93bn | -31.03bn | 172.32bn | 2.97k | -- | 0.852 | -- | 0.8932 | -709.06 | -709.06 | 4,400.23 | 4,618.62 | 0.4943 | 1.48 | 2.88 | 65,002,360.00 | -11.39 | 1.25 | -15.97 | 1.70 | 31.76 | 38.97 | -23.05 | 2.46 | 1.24 | -155.68 | 0.2585 | 76.82 | 3.52 | 7.92 | -329.08 | -- | 4.38 | 0.00 |
| KAKEN PHARMACEUTICAL CO., LTD. | 75.27bn | 8.79bn | 175.26bn | 1.16k | 16.36 | 1.02 | 15.52 | 2.33 | 233.13 | 233.13 | 1,994.15 | 3,730.82 | 0.4522 | 2.06 | 3.65 | 64,660,650.00 | 5.28 | 10.15 | 6.03 | 12.06 | 54.43 | 56.09 | 11.68 | 18.28 | 5.04 | -- | 0.0267 | 37.00 | 1.41 | -5.61 | -28.77 | -15.39 | 6.71 | 0.00 |
| Sosei Group Corporation | 22.76bn | -383.00m | 200.30bn | 198.00 | -- | 3.60 | 214.46 | 8.80 | -4.70 | -4.70 | 278.03 | 679.92 | 0.2473 | -- | 19.92 | 114,964,600.00 | -0.416 | -- | -0.4321 | -- | 95.45 | -- | -1.68 | -- | -- | 2.57 | 0.3475 | -- | 100.32 | -- | -31.24 | -- | -- | -- |
Data as of Jan 27 2023. Currency figures normalised to Mochida Pharmaceutical Co Ltd's reporting currency: Japanese Yen JPY
9.17%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Nomura Asset Management Co., Ltd.as of 30 Dec 2022 | 714.30k | 1.78% |
| The Vanguard Group, Inc.as of 05 Jan 2023 | 660.42k | 1.64% |
| Asset Management One Co., Ltd.as of 30 Sep 2022 | 587.00k | 1.46% |
| BlackRock Fund Advisorsas of 05 Jan 2023 | 354.50k | 0.88% |
| Nikko Asset Management Co., Ltd.as of 06 Jan 2023 | 330.50k | 0.82% |
| Daiwa Asset Management Co. Ltd.as of 30 Dec 2022 | 325.20k | 0.81% |
| Norges Bank Investment Managementas of 31 Dec 2021 | 305.56k | 0.76% |
| Dimensional Fund Advisors LPas of 05 Jan 2023 | 160.70k | 0.40% |
| Mitsubishi UFJ Kokusai Asset Management Co., Ltd.as of 31 Oct 2022 | 147.10k | 0.37% |
| Charles Schwab Investment Management, Inc.as of 05 Jan 2023 | 96.79k | 0.24% |
More ▼
Data from 31 Dec 2021 - 31 Dec 2022Source: FactSet Research Systems Inc.
